SS
RVLP

Steve Schonfeld’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Steve Schonfeld’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-151,400
Closed -$819K – 1957
2020
Q3 		$819K Buy
+151,400
New +$872K 0.02% 755

Other funds holding RVLP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Steve Schonfeld's RVLP Position: Q4 2020 in Review

Steve Schonfeld sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2020, closing a stake of 151,400 shares — an estimated $819K sold.

Steve Schonfeld first reported a position in RVLP in Q3 2020 and held it in 1 quarter. The position peaked at $819K in Q3 2020. 60 funds tracked by Wall St. Rank hold RVLP as of Q4 2020.

  • Steve Schonfeld reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Steve Schonfeld sold 151,400 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2020, an estimated $819K.
  • Steve Schonfeld first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2020 and held it in 1 quarter.
  • Steve Schonfeld's RVL Pharmaceuticals plc Ordinary Shares position peaked at $819K in Q3 2020.
  • 60 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.